Axon Enterprise, Inc. (NASDAQ:AXON) Position Raised by Yousif Capital Management LLC

Yousif Capital Management LLC grew its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 1.6% in the 1st quarter, HoldingsChannel.com reports. The fund owned 9,961 shares of the biotechnology company’s stock after purchasing an additional 157 shares during the quarter. Yousif Capital Management LLC’s holdings in Axon Enterprise were worth $5,239,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Capital World Investors boosted its stake in Axon Enterprise by 86.4% during the 4th quarter. Capital World Investors now owns 1,815,765 shares of the biotechnology company’s stock valued at $1,079,145,000 after purchasing an additional 841,772 shares during the period. Alliancebernstein L.P. grew its holdings in Axon Enterprise by 273.8% in the 4th quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company’s stock worth $659,128,000 after buying an additional 812,337 shares in the last quarter. Norges Bank acquired a new stake in Axon Enterprise in the 4th quarter valued at approximately $482,081,000. GQG Partners LLC acquired a new stake in Axon Enterprise in the 4th quarter valued at approximately $478,349,000. Finally, GAMMA Investing LLC raised its stake in Axon Enterprise by 58,725.5% during the 1st quarter. GAMMA Investing LLC now owns 764,731 shares of the biotechnology company’s stock valued at $402,210,000 after acquiring an additional 763,431 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently issued reports on AXON. The Goldman Sachs Group increased their price target on Axon Enterprise from $730.00 to $830.00 and gave the stock a “buy” rating in a research note on Wednesday, May 14th. Needham & Company LLC upped their price objective on shares of Axon Enterprise from $600.00 to $750.00 and gave the stock a “buy” rating in a report on Thursday, May 8th. Northcoast Research cut shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Bank of America upped their price target on shares of Axon Enterprise from $750.00 to $895.00 and gave the stock a “buy” rating in a research note on Wednesday, June 4th. Finally, Barclays raised their price objective on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an “overweight” rating in a research note on Friday, May 9th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and ten have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $699.55.

Insider Buying and Selling

In other Axon Enterprise news, President Joshua Isner sold 9,000 shares of the business’s stock in a transaction on Monday, May 12th. The shares were sold at an average price of $683.31, for a total transaction of $6,149,790.00. Following the sale, the president now directly owns 308,714 shares of the company’s stock, valued at $210,947,363.34. The trade was a 2.83% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Jeri Williams sold 307 shares of the firm’s stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the sale, the director now directly owns 1,627 shares of the company’s stock, valued at approximately $899,275.44. This trade represents a 15.87% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 43,969 shares of company stock valued at $29,909,594. 4.40% of the stock is owned by corporate insiders.

Axon Enterprise Trading Up 2.1%

Axon Enterprise stock opened at $778.36 on Thursday. The firm has a market cap of $60.60 billion, a price-to-earnings ratio of 201.13, a price-to-earnings-growth ratio of 5.17 and a beta of 1.29. Axon Enterprise, Inc. has a 1 year low of $279.02 and a 1 year high of $806.64. The firm’s 50 day moving average price is $658.49 and its two-hundred day moving average price is $619.52. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.34 by $0.07. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. The business had revenue of $603.63 million for the quarter, compared to analysts’ expectations of $585.67 million. During the same period in the previous year, the firm posted $1.15 EPS. The company’s quarterly revenue was up 31.3% on a year-over-year basis. On average, research analysts predict that Axon Enterprise, Inc. will post 5.8 EPS for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.